BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 8571621)

  • 1. Stark self-referral rules burdened with complexities.
    Barratt K; Katayama A
    Wis Med J; 1995 Dec; 94(12):697-701. PubMed ID: 8571621
    [No Abstract]   [Full Text] [Related]  

  • 2. Physician refer thyself: is Stark II, phase III the final voyage?
    Manchikanti L; McMahon EB
    Pain Physician; 2007 Nov; 10(6):725-41. PubMed ID: 17987094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stark II Final Rule (Phase I): some answers, more questions.
    Shay AW; Murphy SL
    Manag Care Q; 2002; 10(1):38-46. PubMed ID: 15988954
    [No Abstract]   [Full Text] [Related]  

  • 4. Examining the impact of the new Stark rules on joint ventures.
    Washlick JR
    Healthc Financ Manage; 2008 Nov; 62(11):48-52. PubMed ID: 18990836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stark II: the quagmire thickens.
    Ivers D
    J Ark Med Soc; 1998 Jul; 95(2):75-8. PubMed ID: 9676062
    [No Abstract]   [Full Text] [Related]  

  • 6. "Stark" reality: self-referral rule holds risk and opportunity.
    Lebowitz PH
    Radiol Manage; 2001; 23(5):34-9. PubMed ID: 11680255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stark II proposed regulations. Impacting group practices and physician employers.
    Wachler AB; Avery PA
    Mich Health Hosp; 1998; 34(3):37-8. PubMed ID: 10179373
    [No Abstract]   [Full Text] [Related]  

  • 8. The Stark truth about the Stark law: Part II.
    Gosfield AG
    Fam Pract Manag; 2004 Feb; 11(2):41-5. PubMed ID: 15011481
    [No Abstract]   [Full Text] [Related]  

  • 9. Physician group practice implications under the proposed Stark II regulations.
    Sokolow DS
    Health Care Law Mon; 1999 Aug; ():6-9. PubMed ID: 10661984
    [No Abstract]   [Full Text] [Related]  

  • 10. Stark rules. Purchases that pass muster.
    Terry K
    Med Econ; 2006 Dec; 83(24):44-6, 49. PubMed ID: 17249392
    [No Abstract]   [Full Text] [Related]  

  • 11. New Stark II rules on referrals will further restrict medical practices.
    Caesar N
    Manag Care; 1997 May; 6(5):96-8. PubMed ID: 10168642
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes to the federal Stark law that affect diagnostic imaging arrangements.
    Stirewalt K
    Minn Med; 2009 Dec; 92(12):49-51. PubMed ID: 20092174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are you missing out on a valuable profit center?
    Jahn M
    Med Econ; 1997 Jan; 74(1):115-6, 119-22. PubMed ID: 10164326
    [No Abstract]   [Full Text] [Related]  

  • 14. The Stark regulations: so much text; so little substance.
    Conn L; Weissburg C
    Health Syst Rev; 1995; 28(6):25-7, 53-4. PubMed ID: 10153032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How the new Stark II regulations affect group practices.
    Larios D; Meyer A
    Tenn Med; 1998 Apr; 91(4):128-30. PubMed ID: 9564245
    [No Abstract]   [Full Text] [Related]  

  • 16. HCFA issues. Stark II proposed rules.
    Portman RM; Lisa GC
    Bull Am Coll Surg; 1998 Jun; 83(6):20-23. PubMed ID: 10180259
    [No Abstract]   [Full Text] [Related]  

  • 17. The new Stark rules: what does Stark II Phase III mean for healthcare providers?
    Hofstra PS; Bilimoria NM
    J Med Pract Manage; 2008; 23(5):300-3. PubMed ID: 18472609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PHOs, IPAs members must comply with Stark regs.
    Manag Care Strateg; 1998 Dec; 6(12):142-4. PubMed ID: 10351379
    [No Abstract]   [Full Text] [Related]  

  • 19. Proposed Stark II rules: clarification or more confusion?
    Shay A; Francesconi G
    J Health Hosp Law; 1998 Jun; 31(2):95-113. PubMed ID: 10186240
    [No Abstract]   [Full Text] [Related]  

  • 20. How the new Stark rules affect you.
    Guglielmo WJ
    Med Econ; 2008 Feb; 85(3):39-42. PubMed ID: 18314820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.